<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Plaque rupture leading to <z:mp ids='MP_0005048'>thrombosis</z:mp> and occlusion is a major source of <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndromes </plain></SENT>
<SENT sid="1" pm="."><plain>Methods for accurate detection of <z:mp ids='MP_0005048'>thrombosis</z:mp> in veins or arteries may expand our capacity to predict clinical complications and guide therapeutic decisions </plain></SENT>
<SENT sid="2" pm="."><plain>We sought to demonstrate the feasibility of in vivo <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> detection using a fibrin-targeted <z:chebi fb="0" ids="33375">gadolinium</z:chebi> based magnetic resonance contrast agent (EP-1242) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Carotid <z:mp ids='MP_0005048'>thrombosis</z:mp> was induced in 12 guinea pigs by external injury and blood stasis </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> images were obtained after <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation pre- and post- EP-1242 injection, using a T1-weighted high-resolution fast spin-echo sequence </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: An occlusive fibrin-rich <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> was achieved in <z:hpo ids='HP_0000001'>all</z:hpo> animals </plain></SENT>
<SENT sid="6" pm="."><plain>Correlation for <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> location was excellent between MRI and histology (R=0.94; P&lt;0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Contrast-enhanced MRI significantly improved <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> detection when compared to non contrast-enhanced MRI (100% versus 41.6%; p&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> signal intensity (SI) was significantly increased after injection (SI(30 min-post)=4.39+/-0.12 versus 1.0; p&lt;0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>Contrast-to-noise ratio (<z:chebi fb="11" ids="50807">CNR</z:chebi>) was 43.8+/-7.2, 30 min post-injection (P&lt;0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>No enhancement was seen in the uninjured control arteries </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: We demonstrate the feasibility of in vivo MRI for carotid <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> detection using a novel fibrin-targeted contrast agent </plain></SENT>
<SENT sid="12" pm="."><plain>This technique significantly improves detection of small size <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in an animal model of occlusive fibrin-rich <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>